PMID: 2579381Feb 1, 1985Paper

Cardiac dysfunction caused by purified human C3a anaphylatoxin

Proceedings of the National Academy of Sciences of the United States of America
U del BalzoM J Polley

Abstract

The purpose of this investigation was to define the cardiac effects of complement-derived C3a anaphylatoxin, in view of the possibility that cardiac dysfunction may occur as a result of complement activation. Purified human C3a was administered by intracoronary bolus injections into isolated guinea pig hearts. As a function of dose, C3a caused tachycardia, impairment of atrioventricular conduction, left ventricular contractile failure, coronary vasoconstriction, and histamine release. These effects were abolished by cleavage of the COOH-terminal arginine by carboxypeptidase B. The magnitude of C3a-induced tachycardia correlated with the amount of endogenous cardiac histamine released into the coronary effluent. Whereas the tachycardia was markedly reduced by the histamine H2 antagonist cimetidine, the contractile failure and the coronary vasoconstriction caused by C3a were antagonized by the leukotriene antagonist FPL 55712 and by the cyclooxygenase inhibitor indomethacin, respectively. This suggests that histamine, leukotrienes, and vasoactive prostanoates may mediate the various cardiac effects of C3a. Our findings indicate that C3a anaphylatoxin has marked cardiac effects at concentrations that are likely to be attained with...Continue Reading

References

Sep 28, 1972·The New England Journal of Medicine·S RuddyK F Austen
Sep 1, 1982·Klinische Wochenschrift·R LeviJ C Alexander
Oct 4, 1984·The New England Journal of Medicine·R M HakimF K Port
Jul 1, 1983·The British Journal of Radiology·P DawsonS Westaby
Aug 1, 1983·The Journal of Experimental Medicine·M J Polley, R L Nachman
Nov 1, 1980·The Journal of Clinical Investigation·P L SmithL M Lichtenstein
Nov 1, 1980·The Journal of Clinical Investigation·R N PinckardM S Olson
Jan 1, 1981·International Archives of Allergy and Applied Immunology·T E HugliK E Moon
Feb 26, 1981·The New England Journal of Medicine·D E ChenowethJ W Kirklin

❮ Previous
Next ❯

Citations

Oct 1, 1987·Immunopharmacology·F MarceauT E Hugli
Aug 1, 1995·Immunopharmacology·M GardinaliA Agostoni
Feb 9, 2000·Immunopharmacology·J F Regal, A Klos
May 23, 2001·International Immunopharmacology·R NijmeijerC E Hack
Jan 1, 1993·Acta Anaesthesiologica Scandinavica. Supplementum·A Bengtsson
May 17, 2000·The Journal of Clinical Investigation·W ZhouS H Sacks
May 1, 1995·Journal of Cardiac Surgery·J H Gorman, L H Edmunds
Jan 1, 1990·Scandinavian Journal of Thoracic and Cardiovascular Surgery·A G SembO D Mjøs
Jan 1, 1993·Scandinavian Journal of Thoracic and Cardiovascular Surgery. Supplementum·J Vaage, G Valen
Nov 5, 1998·Journal of Cardiothoracic and Vascular Anesthesia·H SegalB J Hunt
Nov 14, 1997·The Journal of Laboratory and Clinical Medicine·Y HiramatsuH L Anderson
Nov 1, 1993·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·M Haeger
Apr 1, 1996·The Annals of Thoracic Surgery·H te VelthuisC R Wildevuur
Jun 1, 1987·Burns, Including Thermal Injury·A Bengtson, M Heideman
Dec 11, 1992·The Annals of Thoracic Surgery·S W Downing, L H Edmunds
Feb 4, 2014·Mediators of Inflammation·A FreyS Frantz
Jul 20, 2014·Molecular Immunology·Knut T LappegårdAnders Hovland
Jan 1, 1990·Scandinavian Journal of Thoracic and Cardiovascular Surgery·K MikawaM Kusunoki
Jun 17, 2003·Journal of Cardiovascular Pharmacology and Therapeutics·Manjeet Singh, Harjot K Saini
Apr 1, 1990·Circulation Research·G L StahlJ C Longhurst
Sep 1, 1989·Circulation Research·U del BalzoR Levi
Aug 1, 1987·The British Journal of Surgery·A BengtsonM Heideman
Jan 1, 1988·Scandinavian Journal of Thoracic and Cardiovascular Surgery·V VidemP Garred

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anaphylaxis

Anaphylaxis is a serious allergic reaction that is rapid in onset and may cause death.

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.

Cardiac Conduction System

The cardiac conduction system is a specialized tract of myocardial cells responsible for maintaining normal cardiac rhythm. Discover the latest research on the cardiac conduction system here.